1 Min Read
Oct 2 (Reuters) - Pluristem Therapeutics Inc:
* Pluristem Therapeutics Inc - $7.9 million non-dilutive grant from European union’s horizon 2020 program has been awarded to nTRACK Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.